{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:54:53Z","timestamp":1776329693962,"version":"3.50.1"},"reference-count":13,"publisher":"Baskent University","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.6002\/ect.2021.0437","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T03:08:51Z","timestamp":1648696131000},"page":"316-320","source":"Crossref","is-referenced-by-count":0,"title":["De Novo Intrahepatic Cholangiocarcinoma After Deceased Donor Liver Transplant in an Adult Patient"],"prefix":"10.6002","volume":"20","author":[{"given":"Hyung Hwan","family":"Moon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Hoon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Il","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Park HW, Hwang S, Ahn CS, et al. De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry. Transplant Proc. 2012;44(3):802-805. doi:10.1016\/j.transproceed.2012.01.027","DOI":"10.1016\/j.transproceed.2012.01.027"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Jung DH, Hwang S, Song GW, et al. Survival benefit of early cancer detection through regular endoscopic screening for de novo gastric and colorectal cancers in Korean liver transplant recipients. Transplant Proc. 2016;48(1):145-151. doi:10.1016\/j.transproceed.2015.12.003","DOI":"10.1016\/j.transproceed.2015.12.003"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B. De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl. 2001;7(11 Suppl 1):S109-118. doi:10.1053\/jlts.2001.28645","DOI":"10.1053\/jlts.2001.28645"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Heneghan MA, Tuttle-Newhall JE, Suhocki PV, et al. De-novo cholangiocarcinoma in the setting of recurrent primary sclerosing cholangitis following liver transplant. Am J Transplant. 2003;3(5):634-638. doi:10.1034\/j.1600-6143.2003.00110.x","DOI":"10.1034\/j.1600-6143.2003.00110.x"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Gong C-S, Yoo M-W, Kim B-S, et al. De novo gastric cancer after liver transplantation. Ann Transplant. 2016;21:386-391. doi:10.12659\/aot.897595","DOI":"10.12659\/AOT.897595"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Channabasappa N, Johnson-Welch S, Mittal N. De novo cholangiocarcinoma after liver transplantation in a pediatric patient. Pediatr Transplant. 2010;14(8):E110-114. doi:10.1111\/j.1399-3046.2009.01220.x","DOI":"10.1111\/j.1399-3046.2009.01220.x"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Mouchli MA, Singh S, Loftus EV, et al. Risk factors and outcomes of de novo cancers (excluding nonmelanoma skin cancer) after liver transplantation for primary sclerosing cholangitis. Transplantation. 2017;101(8):1859-1866. doi:10.1097\/TP.0000000000001725","DOI":"10.1097\/TP.0000000000001725"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Desai R, Collett D, Watson CJ, Johnson P, Evans T, Neuberger J. Cancer transmission from organ donors-unavoidable but low risk. Transplantation. 2012;94(12):1200-1207. doi:10.1097\/TP.0b013e318272df41","DOI":"10.1097\/TP.0b013e318272df41"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Kwong AJ, Kim WR, Lake JR, et al. OPTN\/SRTR 2019 annual data report: liver. Am J Transplant. 2021;21 Suppl 2:208-315. doi:10.1111\/ajt.16494","DOI":"10.1111\/ajt.16494"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Kim JM, Kim DG, Kim J, et al. Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry. Clin Mol Hepatol. 2021;27(3):451-462. doi:10.3350\/cmh.2020.0292","DOI":"10.3350\/cmh.2020.0292"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Ha S-M, Hwang S, Song G-W, et al. Successful introduction of Model for End-stage Liver Disease scoring in deceased donor liver transplantation in Korea: analysis of first 1 year experience at a high-volume transplantation center. Ann Hepatobiliary Pancreat Surg. 2017;21(4):199-204. doi:10.14701\/ahbps.2017.21.4.199","DOI":"10.14701\/ahbps.2017.21.4.199"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Joo DJ. Current status of deceased donor liver transplantation for alcoholic liver disease in Korea in MELD era. Korean J Gastroenterol. 2021;77(1):4-11. doi:10.4166\/kjg.2020.167","DOI":"10.4166\/kjg.2020.167"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Attia M, Silva MA, Mirza DF. The marginal liver donor - an update. Transpl Int. 2008;21(8):713-724. doi:10.1111\/j.1432-2277.2008.00696.x","DOI":"10.1111\/j.1432-2277.2008.00696.x"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T03:30:16Z","timestamp":1648697416000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/archive\/2022\/20\/3\/0\/316\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2021.0437","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}